Theralase Technologies Inc. is facing a tough time in the market, with shares dropping significantly.
In today's trading session, Theralase Technologies Inc. (TLT.V) saw its stock price fall by 1.85%. This decline highlights the ongoing challenges the company faces as it navigates its financial situation.
Advertisement
Theralase Technologies Inc.
TLT.V
TLT.V
Theralase Technologies Inc.
WealthAwesomeMarket cap
$57.44M
52W high
$0.41
52W low
$0.15
1W change
+0.00%
Beta
0.59
Analyst Price Targets
Based on analyst covering TLT
Wall Street analysts forecast TLT stock price to rise 278.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+278.4% Upside
Current Price
C$0.18
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TLT's historical volatility
30-Day Vol
86.9%
Annualized
90-Day Vol
99.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.15
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.17 | C$0.13 โ C$0.24 |
| 60 trading days | C$0.16 | C$0.11 โ C$0.25 |
| 90 trading days | C$0.15 | C$0.09 โ C$0.26 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should keep an eye on Theralase's performance and consider the impact of its recent financial activities and market sentiment.
Theralase's stock price declines to CA$0.27
With a market cap of CA$79.83 million, the company's valuation is under scrutiny as it deals with a challenging trading environment.
Bull case
Theralase has shown growth potential in the past, reporting a 45% increase in revenue during its last earnings call. This suggests there may still be a path to recovery.
Bear case
The recent drop in stock price raises concerns among investors about Theralase's ability to maintain its momentum, especially since there hasnโt been any recent news to boost confidence.
Market Reaction to Theralase's Performance
Advertisement
Today, Theralase Technologies Inc. closed down by 1.85% at CA$0.27. This decline comes amid a lack of new developments that could reassure investors. While the company's recent financial statements showed a revenue increase, the absence of fresh news may have contributed to the stock's downward trend.
Understanding Investor Sentiment
The drop in Theralase's stock price reflects a cautious sentiment among investors. With a market cap of CA$79.83 million, stakeholders are likely weighing the company's growth potential against its current challenges. Investors should watch for upcoming announcements or financial reports to see if this trend continues.
Future Outlook for Theralase Technologies
Despite today's decline, Theralase Technologies has shown promise in previous quarters, including a significant revenue increase. Investors may want to consider the company's long-term potential, especially if it can build on its recent achievements and restore investor confidence.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
